<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPLA) have been shown to enhance <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation by increasing the expression of adhesive receptors such as P-selectin on endothelial cells </plain></SENT>
<SENT sid="1" pm="."><plain>The P-selectin counter-receptor on leucocytes is P-selectin <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> ligand-1 (PSGL-1) </plain></SENT>
<SENT sid="2" pm="."><plain>We have previously described a variable number of tandem repeats (VNTR) polymorphism in the mucin-like region of PSGL-1, with three alleles: allele A, 16 repeats; allele B, 15 repeats; and allele C, 14 repeats </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We compared the PSGL-1 VNTR allele and genotype frequencies in 90 patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) with <z:mp ids='MP_0005048'>thrombosis</z:mp>, 39 patients with persistent aPLA positivity without <z:mp ids='MP_0005048'>thrombosis</z:mp>, and 203 healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The frequency of the B allele was significantly higher in patients with APS with <z:mp ids='MP_0005048'>thrombosis</z:mp> compared with patients without <z:mp ids='MP_0005048'>thrombosis</z:mp> (p = 0.023) </plain></SENT>
<SENT sid="5" pm="."><plain>When we compared the groups by genotype frequencies, we found a markedly higher frequency of the AB genotype in patients with APS with <z:mp ids='MP_0005048'>thrombosis</z:mp> than in aPLA-positive patients without <z:mp ids='MP_0005048'>thrombosis</z:mp> (38.9% vs 10.3%, p = 0.001) or in <z:mpath ids='MPATH_458'>normal</z:mpath> population (38.9% vs 22.2%, p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: We suggest that the VNTR polymorphism of PSGL-1 is a significant determinant of thrombotic predisposition in patients with APS </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, risk appears to correlate best with the combination of alleles inherited rather than with the presence of any particular allele </plain></SENT>
</text></document>